UnitedHealth Group Inc. (UNH) - Q2 2026 10-Q Summary
Business Context and Reporting Period
This report covers the quarterly period ended June 30, 2026. UnitedHealth Group operates two primary businesses: UnitedHealthcare (health benefits) and Optum (health services, including Optum Health, Optum Insight, and Optum Rx). The company is a large accelerated filer with 897.6 million shares of common stock outstanding as of July 31, 2026.
Key Financial Metrics
| Metric (in millions) | Q2 2026 | Q2 2025 | YTD 2026 | YTD 2025 |
|---|---|---|---|---|
| Total Revenues | $112,032 | $111,616 | $223,753 | $221,191 |
| Net Earnings (Attributable to UNH) | $5,484 | $3,406 | $11,764 | $9,698 |
| Diluted EPS | $6.04 | $3.74 | $12.94 | $10.61 |
| Operating Margin | 7.1% | 4.6% | 7.6% | 6.5% |
| Medical Care Ratio (MCR) | 86.7% | 89.4% | 85.3% | 87.1% |
| Cash from Operations (YTD) | $19,964 | $12,644 | ||
| Total Assets | $309,727 | $308,573 | N/A | |
| Total Debt (Current + Long-term) | $73,328 | $78,389 | ||
| Cash & Equivalents | $28,585 | $28,596 | N/A | |
| Investments (Debt + Equity) | $52,921 | $51,151 |
Material Changes vs. Prior Period
- Profitability Surge: Net earnings attributable to shareholders increased 61% year-over-year in Q2 ($5.5B vs $3.4B) and 21% year-to-date. This was driven by a 55% increase in operating earnings ($8.0B vs $5.2B).
- Revenue Stability: Total revenues remained flat in Q2 (+0.4%) and grew 1% YTD. Premium revenue was flat, while Services revenue grew 11% QoQ.
- Medical Cost Management: The Medical Care Ratio (MCR) improved significantly, dropping 2.7 percentage points in Q2 to 86.7%. This was driven by favorable prior period reserve development and fewer people served, offsetting elevated medical cost trends.
- Membership Contraction: UnitedHealthcare served 1.6 million fewer people in Q2 2026 compared to Q2 2025. This included a 9% decline in Medicare Advantage (7.6M vs 8.4M) and a 9% decline in Medicaid (6.8M vs 7.5M) due to benefit design changes, pricing actions, and state exits.
- Segment Performance: UnitedHealthcare operating earnings jumped 90% YoY. Optum Health operating earnings rose 177% YoY, while Optum Rx earnings declined slightly due to lower script volumes.
Guidance, Outlook, and Risks
- Outlook: Management expects Medicare Advantage membership contraction to continue throughout 2026 due to funding pressures and benefit adjustments. Commercial medical cost trends remain elevated due to the No Surprises Act and provider billing intensity.
- Dividends: The Board increased the quarterly cash dividend to $2.32 per share (annualized $9.28) in June 2026, up from $2.21.
- Capital Allocation: The company repurchased 10.5 million shares YTD (including 6.4M via forward contracts settled in July). A $3.0 billion acquisition was completed in July 2026.
- Key Risks:
- Regulatory: Ongoing DOJ litigation regarding Medicare risk adjustment submissions; IRS Notices of Proposed Adjustment (NOPAs) for 2017-2020 transfer pricing.
- Operational: Continued pressure on Medicare Advantage funding rates and Medicaid payment adequacy.
- Strategic: Risks associated with the divestiture of South American operations and integration of new acquisitions.
Investor Verification Checklist
- Medical Cost Trends: Verify the sustainability of the improved MCR given the explicit mention of "elevated" commercial medical cost trends and provider pricing intensity.
- Membership Trajectory: Monitor the rate of decline in Medicare Advantage and Medicaid memberships to assess long-term revenue stability.
- Legal Exposure: Review the status of the DOJ False Claims Act lawsuit and the IRS transfer pricing dispute for potential reserve impacts.
- Divestiture Impact: Assess the final financial impact of the South American business sale and the integration of the $3.0B acquisition.
- Reserve Development: Confirm the magnitude of "favorable prior period reserve development" ($1.25B YTD) to ensure it is not a one-time anomaly masking underlying cost trends.